Latest Announcements

BSE & NSE corporate filings with AI summaries

BSECompany UpdateM&A20 Aug 2026

Prataap Snacks Ltd

Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015 regarding entering into an agreement for acquisition of 100% of the equity share capital of RLOP Food Processing Private ....

Prataap Snacks Ltd has executed a Share Purchase Agreement with RLOP Food Processing Private Ltd for acquisition of 100% of its equity share capital. The acquisition was executed on August 19, 2026, as per the company's earlier intimation dated August 01, 2026.

Read more →📎 1 attachment
NSEAcquisitionM&A20 Aug 2026

Prataap Snacks Limited

Acquisition

Prataap Snacks Limited has informed the Exchange about an update on its acquisition of 100% of the equity share capital of RLOP Food Processing Private Limited.

Read more →📎 1 attachment
BSECompany UpdateM&A20 Aug 2026

Kronox Lab Sciences Ltd

IIFL Capital Services Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Public Announcement for the attention of the Public Shareholders of Kronox Lab Sciences Ltd ("Target ....

Kronox Lab Sciences Ltd has received an open offer from Indo Borax and Chemicals Ltd and Zenrock Chemicals Private Ltd to acquire up to 95,70,000 equity shares, representing 25.79% of the voting share capital, from public shareholders.

Read more →📎 1 attachment
NSEAcquisitionM&A20 Aug 2026

BLS International Services Limited

Acquisition

BLS International Services Limited has acquired an additional equity stake in its subsidiary BLS E-Services Limited through a secondary market transaction, with a cumulative cost of acquisition of Rs. 45.22 Crores.

Read more →📎 1 attachment
BSEBoard MeetingM&A20 Aug 2026

Steelman Telecom Ltd

As per the attachment

The Board of Directors of Steelman Telecom Ltd has approved several items, including the alteration of the Object Clause of the Memorandum of Association, the re-appointment of Mr. Mahendra Bindal as Managing Director, and the proposal to raise funds up to Rs.50 Crore through the issue of Convertible Equity Share Warrants.

Read more →📎 1 attachment
BSECompany UpdateM&A20 Aug 2026

Clean Science and Technology Ltd

Enclosed are the details.

Clean Science and Technology Ltd has informed about the incorporation of its wholly owned subsidiary, Clean Science International B.V., in the Netherlands. The entity is incorporated with an initial capital of EUR 50,000 and will be engaged in the business of selling/distribution/trading/Job work of speciality Chemicals and related products/activities.

Read more →📎 1 attachment
BSECompany Update▲ PositiveM&A20 Aug 2026

Indo Borax & Chemicals Ltd-$

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Press Release ....

Indo Borax & Chemicals Ltd. has announced the acquisition of a 64.26% stake in Kronox Lab Sciences Ltd. through a share purchase agreement. The acquisition is valued at Rs. 246.12 crore, and Indo Borax will also make an open offer to acquire up to 25.79% of Kronox Lab Sciences.

Read more →📎 1 attachment
NSEPress Release▲ PositiveM&A20 Aug 2026

Indo Borax & Chemicals Limited

Press Release

Indo Borax & Chemicals Ltd has announced the acquisition of a 64.26% stake in Kronox Lab Sciences Ltd for Rs. 246.12 crore. The acquisition is expected to strengthen Indo Borax's offerings and fortify its margins.

Read more →📎 1 attachment
NSEUpdates▲ PositiveM&A20 Aug 2026

Kronox Lab Sciences Limited

Updates

Kronox Lab Sciences Limited has announced that Indo Borax and Zenrock Chemicals will acquire a 64.26% stake in the company for Rs. 246.12 crore. The acquisition is expected to be completed within three months.

Read more →📎 1 attachment
BSEOthersM&A20 Aug 2026

P N Gadgil Jewellers Ltd

Outcome of Board Meeting held on August 20, 2026

P N Gadgil Jewellers Ltd has approved the acquisition of 100% stake in Silvostyle Jewellers Limited through fresh issue and acquisition from existing shareholders. The acquisition is expected to strengthen and consolidate the company's jewellery business by integrating Silvostyle Jewellers Limited into the PNG Group.

Read more →📎 1 attachment
NSEOutcome of Board MeetingM&A20 Aug 2026

P N Gadgil Jewellers Limited

Outcome of Board Meeting

P N Gadgil Jewellers Limited has informed the Exchange regarding Outcome of Board Meeting held on August 20, 2026, where the Board of Directors considered and approved the acquisition of 100% stake in Silvostyle Jewellers Limited by way of acquisition of 1,50,00,000 Equity Shares by way of fresh issue and acquisition from existing shareholders.

Read more →📎 1 attachment
NSEScheme of ArrangementM&A20 Aug 2026

K.M.Sugar Mills Limited

Scheme of Arrangement

K.M.Sugar Mills Limited has informed the Exchange about the sanctioning of the Scheme of Arrangement for Demerger of Distillery Division by the Hon'ble National Company Law Tribunal, Allahabad Bench.

Read more →📎 1 attachment
BSECompany UpdateM&A20 Aug 2026

K M Sugar Mills Ltd

Update on the Scheme of Arrangement

K M Sugar Mills Ltd has announced that the Hon'ble National Company Law Tribunal, Allahabad Bench has sanctioned the Scheme of Arrangement for Demerger of its Distillery Division. The order is awaited and will be submitted once available on the website of the Hon'ble NCLT.

Read more →📎 1 attachment
NSEPress Release▲ PositiveM&A20 Aug 2026

Mankind Pharma Limited

Press Release

Mankind Pharma Limited has entered into an exclusive in-licensing agreement with Chongqing Chenan Biopharmaceutical Co., Ltd., China, for the commercialization of two insulin analogues, Insulin Degludec and Insulin Degludec + Aspart Combination, in India. This partnership further strengthens Mankind Pharma's presence in the diabetes segment and expands its portfolio of advanced injectable therapies.

Read more →📎 1 attachment
BSECompany Update▲ PositiveM&A20 Aug 2026

Mankind Pharma Ltd

Please find attached press release dated August 20, 2026.

Mankind Pharma Ltd has entered into an exclusive in-licensing agreement with Chongqing Chenan Biopharmaceutical Co., Ltd. for the commercialization of two insulin analogues, Insulin Degludec and Insulin Degludec + Aspart Combination, in India. This partnership further strengthens Mankind Pharma's presence in the diabetes segment and expands its injectable diabetes portfolio.

Read more →📎 1 attachment
← PreviousPage 109 of 182Next →